Basic Information
Aerius
Regulatory Information
EMEA/H/C/000313
Authorised
January 15, 2001
September 21, 2000
52
March 5, 2025
Company Information
Netherlands
Kloosterstraat 6 5349 AB, Oss
Organon NV
Active Substances Detail
EMA Resources
Detailed Information
Therapeutic Indication
### Therapeutic indication Aerius is indicated for the relief of symptoms associated with: - allergic rhinitis; - urticaria.
Overview Summary
This is a summary of the European public assessment report (EPAR) for Aerius. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Aerius.